The 6 Most Shorted NYSE Stocks
Judging by the most shorted stocks traded on the New York Stock Exchange, short sellers were selective between the November 30 and December 15 settlement dates.
Judging by the most shorted stocks traded on the New York Stock Exchange, short sellers were selective between the November 30 and December 15 settlement dates.
Some inventors shorted Apple's shares during the period that ended December 15, just ahead of negative rumors about iPhone sales.
U.S. car sales are expected to fall in December compared to last year. However, it should be a record month for 2017.
Bitcoin value dropped another 10%, holiday retail sales are expected to hit a new high, Airbus may kill its A380 super jumbo jet, and more important headlines.
Retailers stock their shelves for the holidays, and when certain items don’t sell as well as expected, enterprising bargain-hunters can benefit. Some of the nation’s biggest retailers are offering huge post-holiday discounts on anything…
The legend known as “Jimmy G” has changed the outlook for the San Francisco 49ers — since taking over as starting quarterback, Jimmy Garoppolo has led the 49ers to four straight wins. Garoppolo also…
Apple (NASDAQ: AAPL) issued its proxy. CEO Tim Cook made $12.8 million in the most recent fiscal year, up from $8.7 million the year before. Based on stock price and revenue increases, it is…
General Electric, Genworth Financial, GNC, and PPL Corp. all posted new 52-week lows Wednesday.
Wednesday was a relatively mixed day for the markets on low volume. While the exchanges did not hit new highs they are easily within striking distance. Crude oil was down on the day, but…
Visa, McDonald's, Caterpillar, and UnitedHealth hoisted the DJIA to a small gain Wednesday.
The Forties North Sea pipeline that has been out of service since December 11 is coming back on line with crude flowing through the system at about half of capacity.
Looking ahead to 2018, Disney may be facing some difficulty, but it stands to disrupt and continue to take market share.
Although Shire is not seeing much of a bump in its share price, the firm is creating a lot of value with its most recent submission to the FDA.
Teva Pharmaceutical saw its shares make a small gain on Wednesday after the firm announced the exclusive launch of a generic version of Reyataz capsules in the United States.
The National Association of Realtors reported Wednesday morning that pending home sales rose just 0.2% year over year in November.